-77%

est. 2Y upside i

HealthcareSeries A

AI Clinical Assistant for Doctors

Rank

#3145

Sector

Healthcare AI

Est. Liquidity

~3Y

Data Quality

Data: Low

Bot MD operates in a high-growth healthcare AI market, demonstrating traction with notable customers and a moderate competitive moat.

Last updated: March 10, 2026

Bull (10%)+300%

Bot MD leverages its deep integration capabilities and specialized healthcare focus in Southeast Asia to fend off larger EHR incumbents. It expands its platform to new chronic disease management solutions and secures major partnerships in new APAC markets, driving revenue to $50M+ by 2028 and justifying a $200M+ valuation at 4x revenue, representing a 300% upside.

Base (50%)+50%

Bot MD maintains its niche in patient engagement and workflow automation, growing steadily but facing pressure from EHR vendors offering integrated AI. It reaches $20M in revenue by 2028 and achieves a $75M valuation, a modest 50% increase from the current assumed valuation.

Bear (40%)-80%

Major EHR incumbents like Epic and Athenahealth integrate free or low-cost AI chatbot features, commoditizing Bot MD's core offering. Growth stalls, and the company struggles to differentiate, leading to a down round or acquisition at a significantly lower valuation, potentially $10M, wiping out most common stock value.

Est. time to liquidity~2.5 years

Preference Stack Risk

moderate

Investors hold $5.7M in liquidation preferences, representing 11.4% of the assumed current $50M valuation. In an exit at or below this valuation, common shareholders would see returns after this preference is paid.

Dilution Risk

high

As a Series A company, Bot MD will likely require additional funding rounds (Series B, C, etc.) before a liquidity event, which will lead to further dilution for current common stock or option holders.

Secondary Liquidity

none

There is currently no indication of active secondary markets or tender offers for Bot MD shares, which is typical for a company at this funding stage.

View all 5 open roles at Bot MD →

Last updated: February 17, 2026

Questions to Ask at the Interview

Strategic questions based on Bot MD's data — designed to show you've done your homework.

  • 1

    “With major EHR vendors like Epic and Athenahealth now offering native AI capabilities, how does Bot MD plan to maintain its competitive edge and prevent commoditization of its core chatbot features?”

  • 2

    “Given the estimated revenue range of $1M-$10M, what are the key growth levers Bot MD is focusing on to scale revenue significantly over the next 2-3 years, particularly in new markets like Indonesia, the Philippines, Malaysia, and India?”

  • 3

    “As a Series A company, what is the anticipated timeline for future funding rounds, and how is the company thinking about managing potential dilution for early employees holding common stock or options?”

Community

Valuation Sentiment

Our model estimates -77% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.